Transaction · 0001061983-26-000001

Callos Andrew

Callos Andrew, EVP, CCO, reported an open-market or private sale at CYTOKINETICS INC involving 913.000000 shares for an estimated $56688.17. Reported holdings after the transaction were 50440.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SEVP, CCO

CYTKCYTOKINETICS INC

Filing timeJan 02

Trade dateJan 02, 2026

Filing · SECView on SEC

InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows

Price at filing

$61.73

Pre-filing

1mo ago +7.0%1w ago +7.0%1d ago +7.0%

Returns since

7d +0.0%30d +0.0%90d +7.9%180d +38.1%1y +15.7%

CYTK price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards

CYTK since 2026-01-02Filed 245 days ago · 30 days of pre-filing context shaded

Loading…

Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative

Type: Sell
Identifier: 0001061983-26-000001
Transaction date: Jan 02, 2026
Shares: 913 sh
Estimated value: -$5.66M
Holdings after: 50.4k sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M

Direct Ownership

+10score

Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Chief Commercial Officer

Officer YesDirector No10% NoOther No

Footnotes & amended

No footnotes recorded.

Original filing · 0001061983-26-000001

Related transactions

0 other filings

Same reporting owner

Recent company activity

0 recent txs

CYTK